Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    2292243 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients
Conditions: Breast Cancer;   Breast Neoplasm
Intervention: Drug: 9-cis-Retinoic Acid

Indicates status has not been verified in more than two years